Comprehensive antiphospholipid antibody profiling and unsupervised immune phenotyping in fetal growth restriction.
Non-criteria antiphospholipid antibodies (aPLs) may be associated with adverse obstetric outcomes in patients who do not meet conventional antiphospholipid syndrome (APS) classification criteria. Their clinical relevance in fetal growth restriction (FGR) remains incompletely def…